Anti-glutamic acid decarboxylase-65 (anti-GAD65) autoantibodies have been identified in a variety of rare neurologic disorders; (1–3) most frequently in stiff person syndrome (SPS), a condition characterized by muscle rigidity and overlying painful spasms, typically affecting the axial and limb musculature (3, 4). This evidence concerns the gene GAD2 and nervous system disorder.